BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in BioLineRx Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +2 vs. Q2 2024
- Shares held
- 2.50M
- −941.4K (−27.4%) vs. Q2 2024
- Total value
- $1.34M
- −$615.5K (−31.4%) vs. Q2 2024
- New holders
- 5
- 8 more added
- Sold out
- 3
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $206.7K |
| Q1 2026 | 13 | $45.2K |
| Q4 2025 | 14 | $135.6K |
| Q3 2025 | 14 | $104.3K |
| Q2 2025 | 17 | $302.1K |
| Q1 2025 | 12 | $28.0K |
| Q4 2024 | 32 | $435.9K |
| Q3 2024 | 32 | $1.34M |
| Q2 2024 | 31 | $2.42M |
| Q1 2024 | 28 | $1.47M |
| Q4 2023 | 29 | $1.75M |
| Q3 2023 | 29 | $2.46M |
| Q2 2023 | 26 | $1.97M |
| Q1 2023 | 20 | $2.91M |
| Q4 2022 | 18 | $3.37M |
| Q3 2022 | 28 | $10.3M |
| Q2 2022 | 28 | $1.36M |
| Q1 2022 | 26 | $1.99M |
| Q4 2021 | 30 | $5.09M |
| Q3 2021 | 30 | $6.69M |
| Q2 2021 | 30 | $4.01M |
| Q1 2021 | 29 | $13.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding BioLineRx Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1 | $1 | 0.00% | −1,500−99.9% | Reduced |
| Tradewinds Capital Management, LLC | 200 | $108 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 984 | $527 | 0.00% | −496−33.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,206 | $646 | 0.00% | −200−14.2% | Reduced |
| GWM Advisors LLC | 4,300 | $2.31K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 4,500 | $2.43K | 0.00% | −34,000−88.3% | Reduced |
| Baader Bank INC | 13,250 | $5.09K | 0.00% | +13,250 | New |
| Wealth Enhancement Advisory Services, LLC | 10,500 | $5.63K | 0.00% | +10,500 | New |
| Creative Planning | 12,982 | $6.96K | 0.00% | −99−0.8% | Reduced |
| Qube Research & Technologies Ltd | 13,035 | $6.99K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 16,172 | $8.67K | 0.00% | +16,172 | New |
| Cutter & CO Brokerage, Inc. | 16,667 | $9.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 18,032 | $9.67K | 0.00% | −100,148−84.7% | Reduced |
| Virtu Financial LLC | 21,326 | $11.0K | 0.00% | +21,326 | New |
| Nemes Rush Group LLC | 12,000 | $13.4K | 0.00% | 00.0% | Unchanged |
| Weaver Consulting Group | 29,745 | $15.9K | 0.01% | +12,825+75.8% | Added |
| Gradient Investments LLC | 30,000 | $16.1K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 32,611 | $17.5K | 0.00% | +6,870+26.7% | Added |
| Wells Fargo & Company | 35,035 | $18.8K | 0.00% | −21,000−37.5% | Reduced |
| Rathbone Brothers plc | 39,820 | $21.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 39,993 | $21.4K | 0.00% | 00.0% | Unchanged |
| Orin Green Financial, LLC | 43,000 | $23.1K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 44,135 | $23.7K | 0.00% | +44,135 | New |
| Cetera Investment Advisers | 80,158 | $43.0K | 0.00% | +8,491+11.8% | Added |
| LPL Financial LLC | 92,000 | $49.3K | 0.00% | +10,000+12.2% | Added |
| Atria Wealth Solutions, Inc. | 94,133 | $50.5K | 0.00% | −5,200−5.2% | Reduced |
| Atria Investments LLC | 133,974 | $71.8K | 0.00% | +29,193+27.9% | Added |
| PVG Asset Management Corp | 157,215 | $84.3K | 0.34% | +33,635+27.2% | Added |
| Values First Advisors, Inc. | 197,516 | $105.9K | 0.06% | −6,243−3.1% | Reduced |
| Morgan Stanley | 197,537 | $105.9K | 0.00% | +129,100+188.6% | Added |
| Envestnet Asset Management Inc | 239,186 | $128.2K | 0.00% | +25,353+11.9% | Added |
| Alyeska Investment Group, L.P. | 866,495 | $464.5K | 0.00% | −1,086,871−55.6% | Reduced |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −46,228−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| CVI Holdings, LLC | – | – | – | – | Not filed |